Reuters logo
BRIEF-Orient Pharma gets market license in U.S for its hypolipidemic generic drug Pitavastatin
February 6, 2017 / 10:28 AM / 10 months ago

BRIEF-Orient Pharma gets market license in U.S for its hypolipidemic generic drug Pitavastatin

Feb 6 (Reuters) - Orient Pharma Co Ltd :

* Says it got market license in U.S for its hypolipidemic generic drug named Pitavastatin

Source text in Chinese: goo.gl/bQqaTp

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below